Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Feasibility, Acceptability And Usability Of The InControl Web Platform - A Rando Mized Parallel-Group Pilot Study of Mixed-methods (InControl)

18 de agosto de 2026 actualizado por: Anabela G Silva, Aveiro University

Feasibility, Acceptability And Usability Of The InControl Web Platform - A Mixed-methods Pilot Study

This is a randomized, parallel-group pilot study that employs mixed methods (qualitative and quantitative approaches). The purpose of this study is to assess the feasibility, usability, and acceptability of an intervention with a digital component on the InControl web platform. The intervention is based on education in pain science and exercise, with the goal of managing chronic musculoskeletal pain in older adults. The intervention will be delivered through a combination of digital and in-person components and it will be compared to the usual intervention.

It will also inform the design of a randomized controlled trial to evaluate the cost-effectiveness of InControl.

Descripción general del estudio

Estado

Aún no reclutando

Tipo de estudio

Intervencionista

Inscripción (Estimado)

34

Fase

  • No aplica

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • be 60 years or older;
  • have chronic musculoskeletal pain, defined as pain that persists for more than three months and is felt in the muscles, bones, joints, or tendons at least once a week;
  • know how to use a computer and/or a tablet; iv) have a score of 3 or higher on the Numerical Pain Scale for average pain intensity over the past week;
  • show no cognitive impairment, as determined by the Montreal Cognitive Assessment (MoCA) (validated and with normative data for the Portuguese population) and be available to participate in the study. The MoCA cutoff scores for the absence of cognitive impairment to be considered are adjusted for the participants' age and educational level [primary school (1-4 years), middle school (5-9 years), high school (10-12 years), and college (>12 years)], with 1.5 standard deviations: i) Ages 60-69: elementary school - 17 points, middle school - 21 points, high school and college - 22 points; ii) Ages 70-79: elementary school - 15 points, middle school - 18 points, high school - 20 points, and college - 22 points; iii) Over 80 years old: elementary school - 12 points, middle school - 22 points, high school - 17 points, and college - 19 points.

Exclusion Criteria:

  • inability to read;
  • pain associated with serious conditions (e.g., tumors, fractures);
  • any acute, unstable, or decompensated medical conditions that prevent safe physical exercise. Examples include cardiovascular diseases (recent acute myocardial infarction, unstable angina, uncontrolled cardiac arrhythmias, severe symptomatic aortic stenosis, symptomatic or unstable heart failure, acute myocarditis or pericarditis, acute aortic dissection, active endocarditis, uncontrolled hypertension), respiratory conditions (acute pulmonary embolism, pulmonary infarction, chronic obstructive pulmonary disease, uncontrolled asthma, or recent respiratory exacerbations), metabolic conditions (uncontrolled diabetes mellitus), neurological conditions (stroke, traumatic brain injury, Parkinson's disease), or acute systemic infection.
  • In addition, participants will be screened according to the American College of Sports Medicine's Preparticipation Health Screening algorithm

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: Cuidado usual
Usual care is defined as the treatment that the participant would normally receive such as medication, physical therapy, or any other form of treatment.
Otros nombres:
  • Fisioterapia
  • Terapia física
  • Medicamentos
  • Psychology
  • other intervention
Experimental: InControl intervention
The InControl intervention lasts 8 weeks and combines educational content on pain science and exercise on a digital platform. InControl is the result of a co-creation process between healthcare professionals and older adults with lived experience of chronic musculoskeletal pain.
Otros nombres:
  • Ejercicio
  • Digital intervention
  • Educación en ciencias del dolor.
  • Functional objective
  • In-person

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Rates
Periodo de tiempo: From enrollment to the end of treatment at 8 weeks
inclusion, refusal, exclusion, dropout and retetion
From enrollment to the end of treatment at 8 weeks
System Usability Scale
Periodo de tiempo: At the end of 8 weeks of intervention
Usability evatuated wiht the portuguese version of SUS The score ranges from 0 to 100. Higher scores are interpreted as indicating better usability.
At the end of 8 weeks of intervention
Estructured questionnaire to assess aceptability
Periodo de tiempo: At the end of 8 weeks of intervention
Estructured questionnaire Ten items, with scores ranging from 1 - totally disagree to 5 - totally agree
At the end of 8 weeks of intervention
Semi-structured interview
Periodo de tiempo: At the end of 8 weeks of intervention
Semi-structured interview to explore participants' perceptions about programme acceptability
At the end of 8 weeks of intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Sex
Periodo de tiempo: Baseline
Please indicate the appropriate option: male, female, prefer not to say, other (please specify)
Baseline
Age
Periodo de tiempo: Baseline
number of years
Baseline
Marital status
Periodo de tiempo: Baseline
Select your marital status: Single, Married, In a civil partnership, Divorced Widowed
Baseline
Level of education
Periodo de tiempo: Baseline
Please select your level of education: Can read and write; 4th year of schooling; 6th year of schooling; 9th year of schooling; 12th year of schooling; Bachelor's degree; Other (please specify)
Baseline
Employment status
Periodo de tiempo: Baseline
Please select: Full-time employee, Part-time employee, Domestic worker, Unemployed, Retired, Temporarily unfit for work
Baseline
Weight
Periodo de tiempo: Baseline
weight in kilograms
Baseline
Height
Periodo de tiempo: Baseline
height, in metres
Baseline
Falls
Periodo de tiempo: Baseline
number of falls in the last year
Baseline
Number of medicines
Periodo de tiempo: Baseline
number of regular medicines
Baseline
Comorbidities
Periodo de tiempo: Baseline
Please select: No medical conditions, High blood pressure, Diabetes, Osteoarthritis (please specify the affected area), Cardiovascular conditions, Respiratory conditions, Neurological conditions, Cancer, Arthritis, Osteoporosis, Vision problems, Hearing problems, Other (please specify)
Baseline
EQ-5D-5L
Periodo de tiempo: At baseline and at the end of the 8-week intervention
The EQ-5D-5L score ranges from 1 to 5 for each domain
At baseline and at the end of the 8-week intervention
EQ-VAS
Periodo de tiempo: At baseline and at the end of the 8-week intervention
The score of EQ-VAS ranges from 0 to 100. Higher scores are interpreted as indicating a better perception of health quality
At baseline and at the end of the 8-week intervention
Montreal Cognitive Assessment
Periodo de tiempo: At baseline and at the end of the 8-week intervention
MoCA scores range from 0 to 30. Higher scores indicate better cognitive performance
At baseline and at the end of the 8-week intervention
Brief Pain Inventory
Periodo de tiempo: At baseline and at the end of the 8-week intervention
On the pain severity subscale, scores range from 0 to 40 points. On the pain-related interference subscale, scores range from 0 to 70 points. Higher scores indicate greater severity or pain-related interference, respectively
At baseline and at the end of the 8-week intervention
Location and number of painful sites
Periodo de tiempo: At baseline and at the end of the 8-week intervention
Bodychart
At baseline and at the end of the 8-week intervention
PainDETECT Questionnaire
Periodo de tiempo: At baseline and at the end of 8-week intervention
The score ranges from -1 to 38 points
At baseline and at the end of 8-week intervention
Hand grip strength
Periodo de tiempo: At baseline and at the end of 8-week intervention
Kg
At baseline and at the end of 8-week intervention
Gait speed test
Periodo de tiempo: At baseline and at the end of 8-week intervention
metres per second
At baseline and at the end of 8-week intervention
5-sit-to-stand test
Periodo de tiempo: At baseline and at the end of 8-week intervention
time in seconds
At baseline and at the end of 8-week intervention
Rapid Assessment of Physical Activity
Periodo de tiempo: At baseline and at the end of 8-week intervention
Depending on physical activity, there are five levels of physical activity: sedentary - item 1, ii) slightly active - item 2, iii) regularly slightly active (light activity) - item 3, iv) regularly slightly active - items 4 and 5, and v) active - items 6 and 7
At baseline and at the end of 8-week intervention
Pain Catastrophizing Scale
Periodo de tiempo: At baseline and at the end of 8-week intervention
The minimum score is 0 and the maximum is 52. Higher scores are associated with higher levels of catastrophic thinking
At baseline and at the end of 8-week intervention
Tampa Scale of Kinesiophobia
Periodo de tiempo: At baseline and at the end of 8-week intervention
Scores range from 13 to 52 points. Higher scores are associated with greater fear of movement
At baseline and at the end of 8-week intervention
Geriatric Depression Scale
Periodo de tiempo: At baseline and at the end of 8-week intervention
Scores range from 0 to 15. Higher scores indicate more depressive symptoms
At baseline and at the end of 8-week intervention
Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls
Periodo de tiempo: At baseline and at the end of 8-week intervention
SARC-F. Scores range from 0 to 10. Total scores of 4 or above are suggestive of sarcopenia
At baseline and at the end of 8-week intervention
Patient Global Impression of Change
Periodo de tiempo: At the end of 8-week intervention
Scores range from 1 to 7. Higher scores indicate a greater overall perception of improvement
At the end of 8-week intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Anabela G. Silva, PhD, University of Aveiro

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de septiembre de 2026

Finalización primaria (Estimado)

1 de diciembre de 2026

Finalización del estudio (Estimado)

1 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

28 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

18 de agosto de 2026

Publicado por primera vez (Actual)

19 de agosto de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

19 de agosto de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

18 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir